LSP 6
Key Facts
- Status
Active
- Launch
2018
- Size
550M EUR
- SFDR classification
-
Do You Want to Learn More?
We are eager to explore how we can achieve great things together.
Half-year Report 2025
Active
2018
550M EUR
-
We are eager to explore how we can achieve great things together.
Company | Sector | Market | Entry | Exit |
|---|---|---|---|---|
| Am-Pharma | Life Sciences | Netherlands | 2019 | - |
| Amolyt Pharma | Life Sciences | France | 2019 | 2024 |
| Artios Pharma | Life Sciences | United Kingdom | 2018 | - |
| Arvelle Therapeutics | Life Sciences | Netherlands | 2019 | 2021 |
| Binx Health | Life Sciences | United Kingdom | 2016 | - |
| DNA Script | Life Sciences | France | 2019 | - |
| FoRx Therapeutics | Life Sciences | Switzerland | 2019 | - |
| Imcyse | Life Sciences | Belgium | 2019 | - |
| Innovative Molecules | Life Sciences | Germany | 2021 | - |
| Nkarta | Life Sciences | United States | 2019 | - |
| SNIPR Biome | Life Sciences | Denmark | 2019 | - |
| T-Knife | Life Sciences | Germany | 2021 | - |
| Tenpoints Therapeutics | Life Sciences | United States | 2021 | - |
| VarmX | Life Sciences | Netherlands | 2020 | - |
| Vico Therapeutics | Life Sciences | Belgium | 2019 | - |
| Xilis | Life Sciences | United States | 2021 | - |
| XyloCor Therapeutics | Life Sciences | United States | 2018 | - |